ESR1 and breast carcinoma: In 2019, a report from Lung and colleagues42 showed that the expression of estrogen receptor (ER)-α, the target of endocrine therapies in breast cancer that is expressed by most metastatic breast cancer cells, is regulated by the BM microenvironment.